Chapter 2. Acute and Chronic Inflammation
Chapter 2. Acute and Chronic Inflammation
8. Bradykinin (2006)
(a) causes smooth muscle dilatation
(b) kallikrein causes prohormone degradation to produce bradykinin
(c) in inhibited by Hageman factor
(d) ameliorates pain
(e) is a potent vasoconstrictor
(x) is factor 12
4. Leukocytes move into the tissues from the vasculature (extravasation) (fig 2-8 p57)
(a) by the action of actin and myosin, in association with a number of actin-
regulating proteins
(b) predominantly as neutrophils on the first day post injury, monocytes predominate
on day two
(c) in response to chemical gradients (chemotaxis) endogenous: C5a, lipooxygenase
pathway LTB4, IL-8, exogenous: bacterial products and the actions of integrins
(leukocytes) and selectins (endothelial cells)
(d) in response to the Fc fragment of IgG, C3 complement, cause activation, and
phagocytosis, NOT extravasation
(e) largely in the venules
8. Bradykinin (p65-66)
(a) causes smooth muscle contraction, but interestingly, vasodilation!??
(b) kallikrein causes prohormone degradation (of HMWK) to produce
bradykinin
(c) in produced by Hageman factor, which activates prekallikrein to kallikrein,
which then converts HMWK to bradykinin
*(d) causes pain when injected into the skin
*(e) is a potent vasodilator